Progressive late-onset multiple sclerosis linked to greater disability in Latvian cohort
A Latvian retrospective cohort of 56 patients found that progressive late-onset multiple sclerosis was associated with more motor and sphincter ...
Tag: anti-CD20 therapy
After Natalizumab: Real-World Study Pits Two B-Cell Drugs Head to Head in Multiple Sclerosis
A retrospective real-world study from Milan's San Raffaele institute compares ocrelizumab and ofatumumab as successor therapies for multiple sclerosis patients ...
MS Drug Ocrelizumab Linked to Rare Lung Disease in New Case Series
A new case series and literature review report that ocrelizumab, a leading multiple sclerosis therapy, is associated with a rare ...
New B Cell Therapy Shows Striking Power Against Neuromyelitis Optica
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!